GDF15 and chronic obstructive pulmonary disease: Moreover, GDF15 levels in AECOPD patients are higher than those in stable COPD patients and are strongly associated with reduced lung function, worsened clinical symptoms, increased frequency of acute exacerbation, and an elevated risk of mortality (29–31).